By Vin Gurrieri ( April 15, 2015, 2:04 PM EDT) -- A Pennsylvania federal judge on Tuesday mostly kept intact his decision to allow Suboxone buyers to pursue claims in multidistrict litigation that Reckitt Benckiser Pharmaceuticals Inc. violated antitrust law by using a "product-hopping" scheme to delay generic competition, but tossed certain claims against its parent company....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.